ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Fulcrum Begins of Losmapimod Trial for Hospitalized COVID-19 Patients
July 03, 2020Fulcrum Therapeutics has received early notification from the U.S. Food and Drug Administration (FDA) that the company may proceed with initiating a Phase 3, randomized, double-blind, placebo-controlled trial of losmapimod in higher risk ... -
Fulcrum to Evaluate Losmapimod as Potential COVID-19 Treatment
June 19, 2020Fulcrum Therapeutics has announced plans to evaluate losmapimod as a potential treatment for patients with COVID-19. -
Fulcrum acquires global rights of investigational drug losmapimod from GSK
April 24, 2019Fulcrum Therapeutics has acquired all worldwide development and commercialization rights of investigational drug losmapimod from GlaxoSmithKline (GSK).
Pharma Sources Insight January 2025
